Naturland Holding ZrtBUD:NATURLAND 61 Days Payable is 32.76 as of Jun. 2025, which is 14% below its 10-year median of 37.96. GuruFocus rates BUD:NATURLAND with a GF Score™ of 61/100 and a GF Value™ of Ft2,879.22 (Fairly Valued). The stock has 6 warning signs investors should review. Among 923 Drug Manufacturers companies, Naturland Holding Zrt ranks worse than 86.67% on this metric.
The historical rank and industry rank for Naturland Holding Zrt's Days Payable or its related term are showing as below:
BUD:NATURLAND'
s Days Payable Range Over the Past 10 Years
Min: 26.99 Med: 37.96 Max: 106.08
Current: 34.14
During the past 5 years, Naturland Holding Zrt's highest Days Payable was 106.08. The lowest was 26.99. And the median was 37.96.
BUD:NATURLAND's Days Payable is ranked worse than 86.67% of 923
companies
in the Drug Manufacturers industry
Industry Median: 90.98
vs BUD:NATURLAND: 34.14
Naturland Holding Zrt Days Payable Historical Data
* Premium members only.
The historical data trend for Naturland Holding Zrt's Days Payable can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
BUD:NATURLAND vs ZTS, UTHR, VTRS: Days Payable Comparison
For the Drug Manufacturers - Specialty & Generic subindustry, Naturland Holding Zrt's Days Payable, along with its competitors' market caps and Days Payable data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Naturland Holding Zrt Days Payable vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, Naturland Holding Zrt's Days Payable distribution charts can be found below:
* The bar in red indicates where Naturland Holding Zrt's Days Payable falls into.
Days Payable indicates the number of days that the account payable relative to cost of goods sold the company has. An increase of Days Payable may suggest that the company delays paying its suppliers.
Naturland Holding Zrt's Days Payable for the fiscal year that ended in Dec. 2024 is calculated as
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Naturland Holding Zrt (BUD:NATURLAND) has a Days Payable of 32.76 as of Jun. 2025. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Naturland Holding Zrt and its competitors. This is 14% below median its historical median of 37.96. Over the past decade, Naturland Holding Zrt's Days Payable has ranged from 26.99 to 106.08. According to the industry distribution chart, Naturland Holding Zrt ranks #800 out of 923 companies in the Drug Manufacturers industry, placing it in the top 86.7%.
Is Naturland Holding Zrt's Days Payable too high?
Naturland Holding Zrt's current Days Payable of 32.76 is 14% below median its 10-year median of 37.96. Over the past 10 years, this metric has ranged from a low of 26.99 to a high of 106.08. The Drug Manufacturers industry median Days Payable is 90.98. Naturland Holding Zrt's value of 32.76 is 64% below this industry median. Based on the distribution chart, Naturland Holding Zrt ranks #800 out of 923 companies in the Drug Manufacturers industry, which is in the bottom quartile relative to peers. Overall, Naturland Holding Zrt has a GF Score™ of 61/100 and is considered Fairly Valued, reflecting its overall financial health beyond just this single metric.
How does Naturland Holding Zrt's Days Payable compare to ZTS and UTHR?
According to the Drug Manufacturers industry distribution chart, Naturland Holding Zrt ranks #800 out of 923 companies for Days Payable. This places Naturland Holding Zrt in the lower half of its industry. The industry median Days Payable is 90.98. Naturland Holding Zrt's value of 32.76 is 64% below this benchmark. Historically, Naturland Holding Zrt's own Days Payable has ranged from 26.99 to 106.08 over the past decade. While the company's 10-year median is 37.96 vs. the industry median of 90.98, Naturland Holding Zrt has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Days Payable for a Drug Manufacturers company?
The median Days Payable among Drug Manufacturers companies is 90.98, based on 923 companies in the industry. Companies in the top quartile (top 25%) have a Days Payable significantly above this median, while those in the bottom quartile fall well below. However, Days Payable should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Naturland Holding Zrt's current Days Payable of 32.76 is 64% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Days Payable mean?
A high Days Payable can signal that a stock is expensive relative to its fundamentals. Days payable represents the average amount of days a company waits to pay its invoices from suppliers. View historical data on Naturland Holding Zrt and its competitors. For the Drug Manufacturers industry, the median Days Payable is 90.98 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Naturland Holding Zrt's current Days Payable is 32.76, which is 14% below median its own 10-year median of 37.96. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Naturland Holding Zrt stock overvalued right now?
Based on GuruFocus' analysis, Naturland Holding Zrt (BUD:NATURLAND) is currently considered Fairly Valued. The stock's GF Value™ is Ft2,879.22, compared to a current price of Ft2,820.00 — trading 2.1% below its estimated fair value. The current Days Payable is 32.76, which is 14% below median its 10-year median of 37.96 and 64% below the Drug Manufacturers industry median of 90.98. Naturland Holding Zrt's overall GF Score™ is 61/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Days Payable calculated?
Days Payable is calculated from a company's financial statements. For Naturland Holding Zrt (BUD:NATURLAND), the current Days Payable is 32.76 as of Jun. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Naturland Holding Zrt (BUD:NATURLAND) Overvalued in 2026?
Based on GuruFocus' analysis, Naturland Holding Zrt stock appears to be undervalued.
The current stock price of Ft2,820.00 is trading 2.1% below its estimated GF Value™ of Ft2,879.22.
GuruFocus considers Naturland Holding Zrt to be Fairly Valued.
Key valuation signals for BUD:NATURLAND:
Days Payable: 32.76 (14% below median its 10-year median of 37.96)
GF Value™: Ft2,879.22 vs. price of Ft2,820.00 (2.1% below fair value)
Industry Position: 64% below the Drug Manufacturers median (#800 of 923)
No single metric tells the full story. See the BUD:NATURLAND stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Naturland Holding Zrt thro9ugh its subsidiaries engage in the production of pharmaceutical products. It engages in the development, production, and wholesale of dietary supplements and cosmetics, herbal medicine, teas, and essential oils. The firm offers tablets, suppositories, ointments, and ophthalmic base solutions.
61GF Score
Get the complete analysis for BUD:NATURLAND
Days Payable is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
BUD:NATURLAND has been successfully added to your 
